Medmira Inc  

(Public, CVE:MIR)   Watch this stock  
Find more results for MIR
-0.0050 (-7.14%)
Jul 11 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.06 - 0.06
52 week 0.05 - 0.14
Open 0.06
Vol / Avg. 67,000.00/62,758.00
Mkt cap 33.43M
P/E     -
Div/yield     -
EPS -0.01
Shares 514.36M
Beta 0.08
Inst. own     -

Key stats and ratios

Q1 (Jan '14) 2013
Net profit margin -273.23% -20.10%
Operating margin -222.84% -72.43%
EBITD margin - -106.15%
Return on average assets -121.97% -19.45%
Return on average equity - -
Employees 65 -
CDP Score - -


Suite 1, 155 Chain Lake Drive
+1-902-4501588 (Phone)
+1-902-4501580 (Fax)

Website links


MedMira Inc.( MedMira) is a biotechnology company. The Company is engaged in the development and commercialization of diagnostics and technology platforms. The Company operates in North America, Latin America/Caribbean, Europe and Asia Pacific. It invests in research. The Company�s tests provide hospitals, labs, clinics and individuals with instant diagnosis for diseases, such as HIV and hepatitis C in just three steps. The Company�s tests are sold under the Reveal, Multiplo and Miriad brands. The Company sells its tests through a worldwide network of medical distributors and strategic business development partners with customers in all sectors of the healthcare industry, including laboratories, hospitals, point-of-care facilities, governments, and public health agencies.

Officers and directors

Hermes Chan Chief Executive Officer, Director
Jelle Kuypers Chief Financial Officer
Sing Chan Chief Operating Officer
Marvyn Robar Non-Executive Chairman of the Board
Colin MacGillivray Director
Michael Sidler Director
Markus M. Meile Independent Director
Romano Robusto Independent Director